Inicio>>Anti-human EGFR aptamer, Janelia Fluor® 646 conjugate

Anti-human EGFR aptamer, Janelia Fluor® 646 conjugate

Catalog No.GC50499

High affinity anti-human EGFR aptamer conjugated to Janelia Fluor® 646

Products are for research use only. Not for human use. We do not sell to patients.

Anti-human EGFR aptamer, Janelia Fluor® 646 conjugate Chemical Structure

Tamaño Precio Disponibilidad Cantidad
50 ug
647,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

High affinity anti-human EGFR aptamer conjugated to Janelia Fluor® 646 (Kd = 0.62 nM). Exhibits high affinity and specificity for human epidermal growth factor receptor (EGFR). Displays dense labeling of the stained structures. Suitable for use in super-resolution microscopy techniques. For optimal binding, aptamers require refolding into their tertiary structure prior to use. Please refer to the protocol for information regarding refolding.

Kim et al (2014) Efficient isolation and elution of cellular proteins using aptamer-mediated protein precipitation assay. Biochem.Biophys.Res.Commun. 448 114 PMID:24768638 |Gomes de Castro et al (2017) Aptamers provide superior stainings of cellular receptors studied under super-resolution microscopy. Send to 12 e0173050 PMID:28235049

Reseñas

Review for Anti-human EGFR aptamer, Janelia Fluor® 646 conjugate

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Anti-human EGFR aptamer, Janelia Fluor® 646 conjugate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.